SOBR Safe (SOBR) 10-K 15 Apr 15 2014 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2014	Apr. 13, 2015
Document And Entity Information
Entity Registrant Name	TransBiotec, Inc.
Entity Central Index Key	1425627
Document Type	10-K
Document Period End Date	31-Dec-14
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		58,416,660
Entity Public Float		$88,047
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2014

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2014	Dec. 31, 2013
Current assets
Cash	$623
Total current assets	623
Fixed assets - net	454	1,230
Total Assets	1,077	1,230
Current liabilities
Accounts payable	484,260	421,597
Accrued interest payable	407,684	268,950
Notes payable - current - related parties	697,225	573,516
Notes payable - current, net	871,694	612,342
Notes payable - derivitive liability payable	25,456	150,067
Stock subscription payable - current	28,067	26,000
Related party payables	296,265	190,765
Other payables	241,922	238,085
Total current liabilities	3,052,573	2,481,322
Notes payable - related parties	43,298	167,007
Total Liabilities	3,095,871	2,648,329
Stockholders' Deficit
Common stock, $.00001 par value; 100,000,000 shares authorized; 58,416,660 and 34,146,712 shares issued and outstanding as of December 31 2014 and 2013, respectively	585	342
Additional paid in capital	12,716,630	12,415,639
Accumulated deficit	-15,777,222	-15,032,660
Total Transbiotec, Inc. stockholders' deficit	-3,060,007	-2,616,679
Noncontrolling interest	-34,787	-30,420
Total Stockholders' Deficit	-3,094,794	-2,647,099
Total Liabilities and Stockholders' Deficit	$1,077	$1,230

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Stockholders' Equity
Common stock par value	$0.00	$0.00
Common stock shares authorized	100,000,000	100,000,000
Common stock shares issued	58,416,660	34,146,712
Common stock shares outstanding	58,416,660	34,146,712

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Consolidated Statements Of Operations
Revenues
Operating expenses:
Amortization & depreciation	776	777
General and administrative	505,552	783,848
Total operating expenses	506,328	784,625
Loss from operations	-506,328	-784,625
Other income (expense):
Gain/(Loss) on fair value adjustment - derivatives	-21,559	186,202
Gain on debt reversal		99,805
Interest expense	-188,046	-170,428
Interest expense - beneficial conversion feature	-32,996	-94,161
Total other income (expense)	-242,601	21,418
Loss before provision for income taxes	-748,929	-763,207
Provision for income tax
Net loss	-748,929	-763,207
Less: Net loss attributable to noncontrolling interest	4,367	4,791
Net loss attributable to TranBioTec, Inc.	($744,562)	($758,416)
Net loss per share
(Basic and fully diluted)	($0.02)	($0.02)
Weighted average number of common shares outstanding	39,215,919	32,540,568

CONSOLIDATED_STATEMENT_OF_CHAN

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT (USD $)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Stockholders' Equity - TransBiotec Inc.	Noncontrolling Interest	Total
Biginning Balance, Amount at Dec. 31, 2012	$303	$11,903,279	($14,274,244)	($2,370,662)	($25,629)	($2,396,291)
Beginning Balance, Shares at Dec. 31, 2012	30,315,554
Stock issued for cash, Amount
Stock issued for services, Shares	833,333
Stock issued for services, Amount	9	77,424		77,433		77,433
Stock conversion of note payable , Shares	2,997,825
Stock conversion of note payable, Amount	30	48,970		49,000		49,000
Paid in capital - beneficial conversion feature		76,951		76,951		76,951
Paid in capital - stock option expense		145,997		145,997		145,997
Paid in capital - Equity obligation settlement at fair value		163,018		163,018		163,018
Share exchange - noncontrolling interest					-4,791	-4,791
Net Loss			-758,416	-758,416		-758,416
Ending Balance, Amount at Dec. 31, 2013	342	12,415,639	-15,032,660	-2,616,679	-30,420	-2,647,099
Ending Balance, Shares at Dec. 31, 2013	34,146,712
Stock issued for services, Shares	154,520
Stock issued for services, Amount	2	3,057		3,059		3,059
Stock conversion of note payable , Shares	24,115,428
Stock conversion of note payable, Amount	241	66,878		67,119		67,119
Paid in capital - beneficial conversion feature		15,000		15,000		15,000
Paid in capital - stock option expense		69,886		69,886		69,886
Paid in capital - Equity obligation settlement at fair value		146,170		146,170		146,170
Share exchange - noncontrolling interest					-4,367	-4,367
Net Loss			-744,562	-744,562		-744,562
Ending Balance, Amount at Dec. 31, 2014	$585	$12,716,630	($15,777,222)	($3,060,007)	($34,787)	($3,094,794)
Ending Balance, Shares at Dec. 31, 2014	58,416,660

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Operating Activities:
Net loss	($744,562)	($758,416)
Adjustments to reconcile net loss to net cash used in operating activities
Amortization & depreciation	776	777
Compensatory equity issuances		77,424
Gain on debt reversal		-99,805
Change in fair value of derivative liabilities	21,559	-186,202
Note payable beneficial conversion expense	32,996	94,161
Original issue discount - interest expense		63,004
Stock based compensation	69,888
Changes in assets and liabilities:
Accounts payable	64,730	369,133
Accrued interest payable	138,734
Related party payable	105,500
Other payable	-530	-4,791
Net cash used for operating activities	-310,909	-444,715
Investing Activities:
Fixed asset purchases		511
Net cash used for investing activities		511
Financing Activities:
Notes & loans payable - borrowings	347,266	525,422
Notes & loans payable - payments	-35,734	-82,000
Net cash provided by financing activities	311,532	443,422
Net Change In Cash	623	-782
Cash At The Beginning Of The Period		782
Cash At The End Of The Period	623
Schedule Of Non-Cash Investing And Financing Activities
Debt converted to capital	70,178	96,470
Supplemental Disclosure
Cash paid for interest	9,000	13,396
Cash paid for income taxes

NOTE_1_ORGANIZATION_OPERATIONS

NOTE 1. ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2014
Notes to Financial Statements
NOTE 1. ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	TransBiotec, Inc. (“TransBiotec – DE”), formerly Imagine Media LTD., was incorporated August, 2007 in the State of Delaware. A corporation also named TransBiotec, Inc. (“TransBiotec – CA”) was formed in the state of California July 4, 2004. Effective September 19, 2011 TransBiotec - DE was acquired by TransBiotec - CA in a transaction classified as a reverse acquisition as the shareholders of TransBiotec - CA retained the majority of the outstanding common stock of TransBiotec - DE after the share exchange. The financial statements represent the activity of TransBiotec - CA from July 4 2004 forward, and the consolidated activity of TransBiotec - DE and TransBiotec - CA from September 19, 2011 forward. TransBiotec - DE and TransBiotec - CA are hereinafter referred to collectively as the "Company". The Company has developed and plans to market and sell a non-invasive alcohol sensing system which includes an ignition interlock. The Company has not generated any revenues from its operations.
	Basis of Presentation
	The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) as promulgated in the United States of America.
	Principles of consolidation
	The accompanying unaudited condensed consolidated financial statements include the amounts of the Company and its majority owned subsidiary, Transbiotec-CA. All intercompany accounts and transactions have been eliminated in consolidation.
	Use of Estimates
	The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Specifically, such estimates were made by the Company for the valuation of derivative liability, stock compensation and beneficial conversion feature expenses. Actual results could differ from those estimates.
	Cash and cash equivalents
	The Company considers all highly liquid investments with an original maturity of three months or less as cash equivalents. The Company does not have any cash equivalents as of December 31, 2014 and 2013.
	Property and equipment
	Property and equipment are recorded at cost and depreciated under straight line methods over each item's estimated useful life.
	Income tax
	The Company accounts for income taxes pursuant to ASC 740. Under ASC 740 deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
	Net loss per share
	The net loss per share is computed by dividing the net loss by the weighted average number of shares of common outstanding. Diluted net loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that would then share in the income of the Company, subject to anti-dilution limitations. The Company has 13,755,046 stock options that can be converted to common stock if exercised.
	Financial Instruments
	SC Topic 820 defines fair value, establishes a framework for measuring fair value, establishes a three-level valuation hierarchy for disclosure of fair value measurement and enhances disclosure requirements for fair value measurements. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. The three levels are defined as follows:
	Level 1 – Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
	Level 2 – Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
	Level 3 – Inputs to the valuation methodology are unobservable and significant to the fair value measurement.
	The carrying value of cash, accounts payable, accrued expenses, notes payable, and other payable approximates their fair values due to their short-term maturities.
	Long-Lived Assets
	In accordance with ASC 350, the Company regularly reviews the carrying value of intangible and other long-lived assets for the existence of facts or circumstances, both internally and externally, that may suggest impairment. If impairment testing indicates a lack of recoverability, an impairment loss is recognized by the Company if the carrying amount of a long-lived asset exceeds its fair value.
	Beneficial Conversion Features
	From time to time, the Company may issue convertible notes that may contain an embedded beneficial conversion feature. A beneficial conversion feature exists on the date a convertible note is issued when the fair value of the underlying common stock to which the note is convertible into is in excess of the remaining unallocated proceeds of the note after first considering the allocation of a portion of the note proceeds to the fair value of the warrants, if related warrants have been granted. The intrinsic value of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid in capital. The debt discount is amortized to interest expense over the life of the note using the effective interest method.
	Derivative Instruments
	The fair value of derivative instruments is recorded and shown separately under current liabilities. Changes in fair value are recorded in the consolidated statement of income under other income (expenses).
	The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instruments is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a weighted average Black-Sholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
	Stock based compensation
	The Company has share-based compensation plans under which employees, consultants, suppliers and directors may be granted restricted stock, as well as options and warrants to purchase shares of Company common stock at the fair market value at the time of the grant. Stock-based compensation cost to employees is measured by the Company at the grant date, based on the fair value of the award, over the requisite service period under ASC718. For options issued to employees, the Company recognizes stock compensation costs utilizing the fair value methodology over the related period of benefit. Grants of stock to non-employees and other parties are accounted for in accordance with the ASC 505.
	Recent accounting pronouncement
	In June 2014, the FASB issued ASU 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements. ASU 2014-10 eliminates the distinction of a development stage entity and certain related disclosure requirements, including the elimination of inception-to-date information on the statements of operations, cash flows and stockholders' equity. The amendments in ASU 2014-10 will be effective prospectively for annual reporting periods beginning after December 15, 2014, and interim periods within those annual periods, however early adoption is permitted. The Company adopted ASU 2014-10 during the quarter ended June 30, 2014, thereby no longer presenting or disclosing any information required by Topic 915.
	In August 2014, the FASB issued the FASB Accounting Standards Update No. 2014-15 “Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”). In connection with preparing financial statements for each annual and interim reporting period, an entity’s management should evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued (or within one year after the date that the financial statements are available to be issued when applicable). Management’s evaluation should be based on relevant conditions and events that are known and reasonably knowable at the date that the financial statements are issued (or at the date that the financial statements are available to be issued when applicable). Substantial doubt about an entity’s ability to continue as a going concern exists when relevant conditions and events, considered in the aggregate, indicate that it is probable that the entity will be unable to meet its obligations as they become due within one year after the date that the financial statements are issued (or available to be issued). The term probable is used consistently with its use in Topic 450, Contingencies.
	When management identifies conditions or events that raise substantial doubt about an entity’s ability to continue as a going concern, management should consider whether its plans that are intended to mitigate those relevant conditions or events will alleviate the substantial doubt. The mitigating effect of management’s plans should be considered only to the extent that (1) it is probable that the plans will be effectively implemented and, if so, (2) it is probable that the plans will mitigate the conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern.
	If conditions or events raise substantial doubt about an entity’s ability to continue as a going concern, but the substantial doubt is alleviated as a result of consideration of management’s plans, the entity should disclose information that enables users of the financial statements to understand all of the following (or refer to similar information disclosed elsewhere in the footnotes):
		a.	Principal conditions or events that raised substantial doubt about the entity’s ability to continue as a going concern (before consideration of management’s plans).
		b.	Management’s evaluation of the significance of those conditions or events in relation to the entity’s ability to meet its obligations.
		c.	Management’s plans that alleviated substantial doubt about the entity’s ability to continue as a going concern.
	If conditions or events raise substantial doubt about an entity’s ability to continue as a going concern, but the substantial doubt is not alleviated after consideration of management’s plans, an entity should include a statement in the footnotes indicating that there is substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued (or available to be issued). Additionally, the entity should disclose information that enables users of the financial statements to understand all of the following:
		a.	Principal conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern.
		b.	Management’s evaluation of the significance of those conditions or events in relation to the entity’s ability to meet its obligations.
		c.	Management’s plans that are intended to mitigate the conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern.
	The amendments in this Update are effective for the annual period ending after December 15, 2016, and for the annual periods and interim periods thereafter. Early application is permitted. The Company is currently evaluating the impact of the adoptions of ASU 2014-15 on its consolidated financial statements.
	Minority interest (Noncontrolling interest)
	A subsidiary of the Company has minority members, representing ownership interests of 1.38% at December 31, 2013 and December 31, 2014. The Company accounts for these minority, or noncontrolling interests pursuant to ASC 810-10-65 whereby gains and losses in a subsidiary with a noncontrolling interest are allocated to the noncontrolling interest based on the ownership percentage of the noncontrolling interest, even if that allocation results in a deficit noncontrolling interest balance.

NOTE_2_RELATED_PARTY_TRANSACTI

NOTE 2. RELATED PARTY TRANSACTIONS	12 Months Ended
	Dec. 31, 2014
Notes to Financial Statements
NOTE 2. RELATED PARTY TRANSACTIONS	As of December 31, 2013 and December 31, 2014, the Company had payables due to officers, for accrued compensation and services of $190,765 and $296,265 respectively.

NOTE_3_PROPERTY_EQUIPMENT

NOTE 3. PROPERTY & EQUIPMENT	12 Months Ended
	Dec. 31, 2014
Notes to Financial Statements
NOTE 3. PROPERTY & EQUIPMENT	Fixed asset values recorded at cost are as follows:
		31-Dec-14			31-Dec-13
	Office and Lab Equipment	$	32,127		$	31,616
	Furniture and fixtures		11,556			11,556
			43,683			43,683
	Less accumulated depreciation		(43,229	)		(42,453	)
	Total	$	454		$	1,230
	Depreciation expense for the years ended December 31, 2013 and 2014 was $777 and $776, respectively.

NOTE_4_NOTES_PAYABLE

NOTE 4. NOTES PAYABLE	12 Months Ended
	Dec. 31, 2014
Notes to Financial Statements
NOTE 4. NOTES PAYABLE		31-Dec-14			31-Dec-13
	Note payable to related party, unsecured, due 8/3/2012, interest rate 0%.	$	1,950		$	1,950
	Notes payable to related party, unsecured, due 12/31/2012, interest rate 0%.	$	11,810		$	11,810
	Note payable to related party, unsecured, $731,763, 5-years at 0% simple interest, due 7/1/2016, payment amounts vary each month, various late penalties.	$	726,763		$	726,763
	Note payable to non-related party, unsecured, due 2/8/12, quarterly interest due, convertible at holder’s option at $0.3235688 per TBT - DE share, interest rate 30%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	10,000		$	10,000
	Note payable to non-related party, unsecured, due 2/8/12, quarterly interest due, convertible at holder’s option at $0.3235688 per TBT - DE share, interest rate 30%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	25,000		$	25,000
	Note payable to non-related party, unsecured, due 2/17/12, quarterly interest due, convertible at holder’s option at $0.3235688 per TBT - DE share, interest rate 30%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	25,000		$	25,000
	Note payable to non-related party, unsecured, due 2/18/12, quarterly interest due, convertible at holder’s option at $0.3235688 per TBT - DE share, interest rate 30%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	10,000		$	10,000
	Note payable to non-related party, unsecured, due 2/18/13, annual interest due, convertible at holder’s option at $0.3235688 per TBT-DE share, interest rate 18%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	750		$	750
	Note payable to non-related party, unsecured, due 2/18/13, annual interest due, convertible at holder’s option at $0.3235688 per TBT-DE share, interest rate 18%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	6,875		$	6,875
	Note payable to non-related party, unsecured, due 2/15/13, annual interest due, convertible at holder’s option at $0.3235688 per TBT-DE share, interest rate 12%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	2,500		$	2,500
	Note payable to non-related party, unsecured, due 2/20/13, annual interest due, convertible at holder’s option at $0.3235688 per TBT-DE share, interest rate 12%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	3,750		$	3,750
	Note payable to non-related party, unsecured, due 2/21/13, annual interest due, convertible at holder’s option at $0.3235688 per TBT-DE. share, interest rate 12%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	2,625		$	2,625
	Note payable to non-related party, unsecured, due 3/20/13, annual interest due, convertible at holder’s option at $0.3235688 per TBT-DE share, interest rate 12%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	5,433		$	5,433
	Note payable to non-related party, unsecured, due 3/22/13, annual interest due, convertible at holder’s option at $0.3235688 per TBT-DE share, interest rate 12%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	3,203		$	3,203
	Note payable to non-related party, unsecured, due 2/25/13, annual interest due, convertible at holder’s option at 51% of market as defined, interest rate 8%, conversion limited to total beneficial ownership of 4.99%. (Fully converted at December 31, 2014).	$	-		$	19,250
	Note payable to non-related party, unsecured, due 4/19/13, annual interest due, convertible at holder’s option at 51% of market as defined, interest rate 8%, conversion limited to total beneficial ownership of 4.99%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue and/or the continued conversion of the company’s stock.	$	6,605		$	52,500
	Note payable to non-related party, unsecured, due 08/29/2013, simple interest 8% convertible at holder’s option at $.249 per TBT-CA share.	$	15,000		$	15,000
	Currently in default.
	Note payable to non-related party, unsecured, due 03/01/2013, simple interest 9%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	5,000		$	5,000
	Note payable to non-related party, unsecured, due 12/13/2013, simple interest 7%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	5,342		$	5,342
	Note payable to non-related party, unsecured, due 01/31/2013, simple interest 18%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	3,938		$	3,938
	Note payable to non-related party, unsecured, due on demand, simple interest 7%, convertible at anytime into common stock at 65% of market closing price on previous day	$	-		$	25,000
	Note payable to non-related party, unsecured, due 01/07/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interest	$	15,000		$	15,000
	to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.
	Note payable to non-related party, unsecured, due 01/15/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	5,000		$	5,000
	Note payable to non-related party, unsecured, due 01/20/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	65,272		$	65,272
	Note payable to non-related party, unsecured, due 03/28/2013, $13,000 in interest (1 month). Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	17,000		$	32,000
	Note payable to non-related party, unsecured, due 01/23/2014, simple interest 9%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	50,000		$	50,000
	Note payable to non-related party, unsecured, due 04/28/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	9,440		$	9,440
	Note payable to non-related party, unsecured, due 05/05/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	50,060		$	50,060
	Note payable to non-related party, unsecured, due 07/02/2014, simple interest 9%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	15,000		$	15,000
	Note payable to non-related party, unsecured, due 10/25/2013, simple interest 18%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	2,000		$	2,000
	Note payable to non-related party, unsecured, due 07/29/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interestto be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	1,900		$	1,900
	Note payable to non-related party, unsecured, due 09/19/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	10,000		$	10,000
	Note payable to non-related party, unsecured, due 09/19/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	65,000		$	65,000
	Note payable to non-related party, unsecured, due 09/29/2014, simple interest 7%, default interest 10%, stock option. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	20,000		$	20,000
	Note payable to non-related party, unsecured, due 12/27/2013, simple interest 9%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	15,000		$	15,000
	Note payable to non-related party, unsecured, due 10/28/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	2,500		$	2,500
	Note payable to non-related party, unsecured, due 10/29/2014, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenu. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	10,000		$	10,000
	Note payable to non-related party, unsecured, due 11/10/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	5,000		$	5,000
	Note payable to non-related party, unsecured, due 11/20/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	20,000		$	20,000
	Note payable to non-related party, unsecured, due 12/02/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	5,000		$	5,000
	Note payable to non-related party, unsecured, due 1/27/2014, simple interest 10%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	4,235		$	5,000
	Note payable to non-related party, unsecured, due 1/07/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	25,000		$	-
	Note payable to non-related party, unsecured, due 1/28/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	1,253		$	-
	Note payable to non-related party, unsecured, due 1/29/2015, simple interest 7%, default interest 10%. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	3,500		$	-
	Note payable to non-related party, unsecured, due 2/10/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	990		$	-
	Note payable to non-related party, unsecured, due 2/17/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	4,500		$	-
	Note payable to non-related party, unsecured, due 2/20/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	5,000		$	-
	Note payable to non-related party, unsecured, due 3/10/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	2,500		$	-
	Note payable to non-related party, unsecured, due 3/31/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	2,500		$	-
	Note payable to non-related party, unsecured, due 4/03/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	5,890		$	-
	Note payable to non-related party, unsecured, due 4/08/2015, interest up to 7%, convertible up to the due date.	$	15,000		$	-
	Note payable to non-related party, unsecured, due 4/10/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	4,331		$	-
	Note payable to non-related party, unsecured, due 4/27/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	2,500		$	-
	Note payable to non-related party, unsecured, due 5/13/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	5,360		$	-
	Note payable to non-related party, unsecured, due 9/11/2014, simple interest 10%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	5,000		$	-
	Note payable to non-related party, unsecured, due 5/26/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	895		$	-
	Note payable to non-related party, unsecured, due 6/10/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	3,207		$	-
	Note payable to non-related party, unsecured, due 6/17/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	600		$	-
	Note payable to non-related party, unsecured, due 7/09/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	3,750		$	-
	Note payable to non-related party, unsecured, due 8/05/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	10,000		$	-
	Note payable to non-related party, unsecured, due 9/03/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	1,000		$	-
Note payable to non-related party, unsecured, due 10/19/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	1,486		$	-
Note payable to non-related party, unsecured, due 10/22/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	3,500		$	-
Note payable to non-related party, unsecured, due 10/28/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	4,360		$	-
Note payable to non-related party, unsecured, due 11/11/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	5,810		$	-
Note payable to non-related party, unsecured, due 11/19/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	15,000		$	-
Note payable to non-related party, unsecured, due 12/02/2015, simple interest 7%, default interest 10%.	$	214,334		$	-
	$	1,617,217		$	1,375,861
Less note discounts		(5,000	)		(22,996	)
Less current - related parties		(697,225	)		(573,516	)
Less current – non-related parties		(871,694	)		(612,342	)
Long-term – related parties	$	43,298		$	167,007
Required principal payments from December 31, 2014 forward are as follows:
2015		$	1,573,919
2016		$	43,298
2017		$	-
2018		$	-
2019		$	-
		$	1,617,217
Interest expense under notes payable for the years ended December 31, 2013 and December 31, 2014 was $170,428 and $188,046, respectively.
During the years ended December 31, 2013 and December 31, 2014 the Company recognized a beneficial conversion feature expense on borrowing from convertible notes of $94,161and $32,996 respectively. During the years ended December 31, 2013 and December 31, 2014 the unamortized note discount from the beneficial conversion feature was $22,996 and $5,000, respectively.
In 2012 the company borrowed $110,000 under convertible notes with a variable conversion price based on a percentage of market price. Notes converted at December 31, 2013 and December 31, 2014 were $47,500 and $103,395, respectively. The Company determined that these notes have an embedded derivative and are therefore accounted for at fair value. The Company recorded fair market value adjustments for the years ended December 31, 2013 and December 31, 2014 of $11,969 and $21,559, respectively. The fair market value adjustments were based on the Black-Sholes method using the following assumptions: risk free rates ranging between 0.10% - 0.21%, dividend yield of 0%, expected life of 1 year, volatility between 128% - 354%. The fair value derivative liability under the notes as of December 31, 2013 and December 31, 2014 was $150,067 and $25,456 respectively.

NOTE_5_INCOME_TAXES

NOTE 5. INCOME TAXES	12 Months Ended
	Dec. 31, 2014
Notes to Financial Statements
NOTE 5. INCOME TAXES	Deferred income taxes arise from the temporary differences between financial statement and income tax recognition of net operating losses. These loss carryovers are limited under the Internal Revenue Code should a significant change in ownership occur.
	At December 31, 2013 and 2014 the Company had net operating loss carry forwards of approximately $5,765,000 and $6,383,000 respectively, which begin to expire in 2034. The deferred tax asset of at each date of $1,153,000 and $1,277,000 created by the net operating losses has been offset by a 100% valuation allowance. The change in the valuation allowance in 2013 and 2014 was $140,000 and $123,000. The Company has not filed tax returns however management believes there are no taxes due as of December 31, 2014 and 2013.

NOTE_6_STOCK_OPTIONS_AND_SUBSC

NOTE 6. STOCK OPTIONS AND SUBSCRIPTIONS PAYABLE	12 Months Ended
	Dec. 31, 2014
Notes to Financial Statements
NOTE 6. STOCK OPTIONS AND SUBSCRIPTIONS PAYABLE	The Company accounts for employee and non-employee stock options under ASC 718 and ASC 505, whereby option costs are recorded based on the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. Unless otherwise provided for, the Company covers option exercises by issuing new shares.
	The Company’s stock option activity is described below.
	Non-employee stock options
	At the beginning of 2012, the Company had 22,500 options outstanding for shares in Transbiotec – CA. During the year ended December 31, 2012 no options were exercised or expired, leaving a December 31, 2012 outstanding balance of 22,500 non-employee stock options, exercisable at prices from $0.10 - $0.15 per share with the option terms expiring from January 2012 through January 2015. All of these options are for the stock of TransBiotec - CA. During the year ended December 31, 2013 no options were exercised or expired, leaving a December 31, 2013 outstanding balance of 22,500 non-employee stock options, exercisable at $0.10 per share with the option terms expiring in January 2015. During the year ended December 31, 2014, 20,000 options were exercised, leaving a December 31, 2014 outstanding balance of 2,500 non-employee stock options, exercisable at $0.10 per share with the option terms expiring in January 2015.All outstanding options are for the stock of TransBiotec-CA
	During 2012 the Company granted 29,678 stock options for shares in Transbiotec - DE. The fair value of the option grants was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions: risk free interest rate of 0.8%, dividend yield of 0%, expected life of five years, volatility of 189%. No options were exercised or expired, leaving a December 31, 2012 outstanding balance of 29,678 options for Transbiotec – DE. The Company incurred and recorded compensation expense under these stock option grants of $4,042 in 2012.
	During 2013 the Company granted 5,321,735 stock options for shares in Transbiotec - DE. The fair value of the option grants was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions: risk free interest rates between 7% - 14%, dividend yield of 0%, expected life of five years, volatility between 179% - 186%. No options were exercised or expired, leaving a December 31, 2013 outstanding balance of 5,351,413 options for Transbiotec – DE. The Company incurred and recorded compensation expense under these stock option grants of $145,997 in 2013.
	During 2014 the Company granted 8,403,633 stock options for shares in Transbiotec - DE. The fair value of the option grants was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions: risk free interest rate between 1.55% - 1.77%, dividend yield of 0%, expected life of five years, a volatility range of 147% - 178%. No options were exercised or expired, leaving a December 31, 2014 outstanding balance of 13,755,046 options for Transbiotec – DE. The Company incurred and recorded compensation expense under these stock option grants of $69,886 during the year ended December 31, 2014.
	A summary of stock option activity for California is as follows:
			Number of				Weighted Average Exercise
			Shares				Price
	Outstanding at December 31, 2013			22,500			$	0.15
	Granted			-				-
	Exercised			20,000				0.35
	Forfeited			-				-
	Outstanding at December 31, 2014			2,500			$	0.1
	Following is a summary of the status of options for California outstanding at December 31, 2014:
	Exercise				Number			Weighted		Weighted				Exercised at
	Price				of Shares			Average		Average				Dec. 31, 2014
								Contractual		Exercise
								Life		Price
	$	0.1				1,500		5 years			0.1				-
	$	0.1				1,000		5 years			0.1				-
	Total					2,500				$	0.1				-
	A summary of stock option activity for Delaware is as follows:
			Number				Weighted
			of Shares				Average
							Exercise
							Price
	Outstanding at December 31, 2013			5,351,413			$	0.09
	Granted			8,403,633				0.02
	Exercised			-				-
	Forfeited			-				-
	Outstanding at December 31, 2014		$	13,755,046			$	0.0295
	Following is a summary of the status of options for Delaware outstanding at December 31, 2014:
	Exercise				Number				Remaining			Weighted				Exercised at
	Price				of Shares				Contractual			Average				Dec. 31, 2014
									Life			Exercise
												Price
	$	0.09				29,678			3 years				0.09				-
	$	0.17				83,333			4 years				0.17				-
	$	0.17				27,778			4 years				0.17				-
	$	0.17				362,624			4 years				0.17				-
	$	0.13				80,914			4 years				0.13				-
	$	0.13				429,086			4 years				0.13				-
	$	0.06				38,000			4 years				0.06				-
	$	0.04				250,000			4 years				0.04				-
	$	0.04				1,625,000			4 years				0.04				-
	$	0.05				400,000			4 years				0.05				-
	$	0.04				75,000			4 years				0.04				-
	$	0.04				300,000			4 years				0.04				-
	$	0.02				300,000			4 years				0.02				-
	$	0.02				1,200,000			4 years				0.02				-
	$	0.04				150,000			4 years				0.04				-
	$	0.0125				1,200,000			5 years				0.0125
	$	0.015				50,137			5 years				0.015				-
	$	0.015				140,000			5 years				0.015				-
	$	0.019				31,256			5 years				0.019				-
	$	0.0161				167,702			5 years				0.0161				-
	$	0.0147				204,082			5 years				0.0147				-
	$	0.02				75,000			5 years				0.02				-
	$	0.0198				75,758			5 years				0.0198				-
	$	0.0213				165,915			5 years				0.0213				-
	$	0.0195				133,262			5 years				0.0195				-
	$	0.0188				79,787			5 years				0.0188				-
$	0.014				229,714			5 years				0.014				-
$	0.019				50,000			5 years				0.019				-
$	0.0127				42,283			5 years				0.0127				-
$	0.009				213,833			5 years				0.009				-
$	0.0074				48,649			5 years				0.0074				-
$	0.006				375,000			5 years				0.006				-
$	0.0098				612,245			5 years				0.0098				-
$	0.0098				61,224			5 years				0.0098				-
$	0.25				25,000			5 years				0.25				-
$	0.068				450,000			5 years				0.068				-
$	0.0072				123,828			5 years				0.0072				-
$	0.0056				375,000			5 years				0.0056				-
$	0.007				250,000			5 years				0.007				-
$	0.007				373,714			5 years				0.007				-
$	0.0041				850,244			5 years				0.0041				-
$	0.0045				2,000,000			5 years				0.0045				-
Total					13,755,046						$	0.0295				-
Employee stock options
The parent company had no outstanding employee stock options.
Stock subscriptions payable
At December 31, 2014, the Company had stock subscriptions payable of $28,067 for 26,000 common shares to be issued.

NOTE_7_GOING_CONCERN

NOTE 7. GOING CONCERN	12 Months Ended
	Dec. 31, 2014
Notes to Financial Statements
NOTE 7. GOING CONCERN	The Company has suffered recurring losses from operations and has a working capital deficit and stockholders' deficit, and in all likelihood will be required to make significant future expenditures in connection with continuing marketing efforts along with general administrative expenses. As of December 31, 2014, the accumulated deficit is $15,777,222. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.
	The Company may raise additional capital through the sale of its equity securities, through an offering of debt securities, or through borrowings from financial institutions or others. By doing so, the Company hopes to generate revenues from sales of its alcohol sensing and ignition lock systems. Management believes that actions presently being taken to obtain additional funding provide the opportunity for the Company to continue as a going concern.

NOTE_9_COMMON_STOCK

NOTE 9. COMMON STOCK	12 Months Ended
	Dec. 31, 2014
Notes to Financial Statements
NOTE 8. COMMON STOCK	On February 1, 2013, the Company converted a note payable of $12,000 into 291,262 shares of its common stock, with a purchase price $0.0412 per share.
	On February 6, 2013, the Company entered into an agreement with an unrelated third-party consultant. As payment for the consultant’s services, the Company issued 150,000 shares of its common stock on said date valued at $22,500 with a purchase price of $0.15 per share.
	On February 26, 2013, the Company entered into an agreement with an unrelated third-party consultant. As payment for the consultant’s services, the Company issued 450,000 shares of its common stock on said date valued at $30,600 with a purchase price of $0.068 per share.
	On February 27, 2013, the Company entered into an agreement with an unrelated third-party consultant. As payment for the consultant’s services, the Company issued 50,000 shares of its common stock on said date valued at $16,000 with a purchase price of $0.32 per share.
	On February 27, 2013, the Company entered into an agreement with an unrelated third-party consultant. As payment for the consultant’s services, the Company issued 33,333 shares of its common stock on said date valued at $2,333 with a purchase price of $0.07 per share.
	On May 9, 2013, the Company converted a note payable of $12,000 into 759,494 shares of its common stock, with a purchase price $0.0158 per share.
	On July 8, 2013, the Company entered into an agreement with an unrelated third-party consultant. As payment for the consultant’s services, the Company issued 150,000 shares of its common stock on said date valued at $6,000 with a purchase price of $0.04 per share.
	On July 12, 2013, the Company converted a note payable of $10,000 into 775,194 shares of its common stock, with a purchase price $0.0129 per share.
	On August 12, 2013, the Company converted a note payable of $15,000 into 1,171,875 shares of its common stock, with a purchase price $0.0128 per share.
	On February 10, 2014, the Company converted a note payable of $4,650 into 1,291,667 shares of its common stock, with a purchase price $0.0036 per share.
	On April 24, 2014, the Company exchanged 20,000 of TBT-CA shares for 154,520 TBT-Publico shares at an exchange rate of $7.7263 per share.
	On May 13, 2014, the Company converted a note payable of $9,000 into 1,764,706 shares of its common stock, with a purchase price $0.0051 per share.
	On May 30, 2014, the Company converted a note payable of $265, including $210 of accrued interest into 50,000 shares of its common stock, with a purchase price $0.0095 per share.
	On June 3, 2014, the Company converted a note payable of $5,600, including $1,500 in accrued interest into 1,690,476 shares of its common stock, with a purchase price $0.0042 per share.
	On July 2, 2014, the Company converted a note payable of $6,360 into 1,766,667 shares of its common stock, with a purchase price $0.0036 per share.
	On August 19, 2014, the Company converted a note payable of $7,135 into 2,038,571 shares of its common stock, with a purchase price $0.0035 per share.
	On October 21, 2014, the Company converted a note payable of $6,520 into 2,037,500 shares of its common stock, with a purchase price $0.0032 per share.
	On October 22, 2014, the Company converted a note payable of $6,270 into 1,959,375 shares of its common stock, with a purchase price $0.0032 per share.
	On October 29, 2014, the Company converted a note payable of $5,780 into 2,140,741 shares of its common stock, with a purchase price $0.0027 per share.
	On November 20, 2014, the Company converted a note payable of $4,690 into 2,345,000 shares of its common stock, with a purchase price $0.0020 per share.
	On November 24, 2014, the Company converted a note payable of $3,985 into 2,344,118 shares of its common stock, with a purchase price $0.0017 per share.
	On December 16, 2014, the Company converted a note payable of $3,280 into 2,342,857 shares of its common stock, with a purchase price $0.0014 per share.
	On December 30, 2014, the Company converted a note payable of $1,875 into 2,343,750 shares of its common stock, with a purchase price $0.0008 per share.

NOTE_1_ORGANIZATION_OPERATIONS1

NOTE 1. ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2014
Note 1. Organization Operations And Summary Of Significant Accounting Policies Policies
Basis of Presentation	The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) as promulgated in the United States of America.
Principles of Consolidation	The accompanying unaudited condensed consolidated financial statements include the amounts of the Company and its majority owned subsidiary, Transbiotec-CA. All intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Specifically, such estimates were made by the Company for the valuation of derivative liability, stock compensation and beneficial conversion feature expenses. Actual results could differ from those estimates.
Cash and cash equivalents	The Company considers all highly liquid investments with an original maturity of three months or less as cash equivalents. The Company does not have any cash equivalents as of December 31, 2014 and 2013.
Property and equipment	Property and equipment are recorded at cost and depreciated under straight line methods over each item's estimated useful life.
Income tax	The Company accounts for income taxes pursuant to ASC 740. Under ASC 740 deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
Net loss per share	The net loss per share is computed by dividing the net loss by the weighted average number of shares of common outstanding. Diluted net loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that would then share in the income of the Company, subject to anti-dilution limitations. The Company has 13,755,046 stock options that can be converted to common stock if exercised.
Financial Instruments	SC Topic 820 defines fair value, establishes a framework for measuring fair value, establishes a three-level valuation hierarchy for disclosure of fair value measurement and enhances disclosure requirements for fair value measurements. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. The three levels are defined as follows:
	Level 1 – Inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
	Level 2 – Inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
	Level 3 – Inputs to the valuation methodology are unobservable and significant to the fair value measurement.
	The carrying value of cash, accounts payable, accrued expenses, notes payable, and other payable approximates their fair values due to their short-term maturities.
Long-Lived Assets	In accordance with ASC 350, the Company regularly reviews the carrying value of intangible and other long-lived assets for the existence of facts or circumstances, both internally and externally, that may suggest impairment. If impairment testing indicates a lack of recoverability, an impairment loss is recognized by the Company if the carrying amount of a long-lived asset exceeds its fair value.
Beneficial Conversion Features	From time to time, the Company may issue convertible notes that may contain an embedded beneficial conversion feature. A beneficial conversion feature exists on the date a convertible note is issued when the fair value of the underlying common stock to which the note is convertible into is in excess of the remaining unallocated proceeds of the note after first considering the allocation of a portion of the note proceeds to the fair value of the warrants, if related warrants have been granted. The intrinsic value of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid in capital. The debt discount is amortized to interest expense over the life of the note using the effective interest method.
Derivative Instruments	The fair value of derivative instruments is recorded and shown separately under current liabilities. Changes in fair value are recorded in the consolidated statement of income under other income (expenses).
	The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instruments is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a weighted average Black-Sholes-Merton option pricing model to value the
	derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
Stock based compensation	The Company has share-based compensation plans under which employees, consultants, suppliers and directors may be granted restricted stock, as well as options and warrants to purchase shares of Company common stock at the fair market value at the time of the grant. Stock-based compensation cost to employees is measured by the Company at the grant date, based on the fair value of the award, over the requisite service period under ASC718. For options issued to employees, the Company recognizes stock compensation costs utilizing the fair value methodology over the related period of benefit. Grants of stock to non-employees and other parties are accounted for in accordance with the ASC 505.
Recent accounting pronouncement	In June 2014, the FASB issued ASU 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements. ASU 2014-10 eliminates the distinction of a development stage entity and certain related disclosure requirements, including the elimination of inception-to-date information on the statements of operations, cash flows and stockholders' equity. The amendments in ASU 2014-10 will be effective prospectively for annual reporting periods beginning after December 15, 2014, and interim periods within those annual periods, however early adoption is permitted. The Company adopted ASU 2014-10 during the quarter ended June 30, 2014, thereby no longer presenting or disclosing any information required by Topic 915.
	In August 2014, the FASB issued the FASB Accounting Standards Update No. 2014-15 “Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”). In connection with preparing financial statements for each annual and interim reporting period, an entity’s management should evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued (or within one year after the date that the financial statements are available to be issued when applicable). Management’s evaluation should be based on relevant conditions and events that are known and reasonably knowable at the date that the financial statements are issued (or at the date that the financial statements are available to be issued when applicable). Substantial doubt about an entity’s ability to continue as a going concern exists when relevant conditions and events, considered in the aggregate, indicate that it is probable that the entity will be unable to meet its obligations as they become due within one year after the date that the financial statements are issued (or available to be issued). The term probable is used consistently with its use in Topic 450, Contingencies.
	When management identifies conditions or events that raise substantial doubt about an entity’s ability to continue as a going concern, management should consider whether its plans that are intended to mitigate those relevant conditions or events will alleviate the substantial doubt. The mitigating effect of management’s plans should be considered only to the extent that (1) it is probable that the plans will be effectively implemented and, if so, (2) it is probable that the plans will mitigate the conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern.
	If conditions or events raise substantial doubt about an entity’s ability to continue as a going concern, but the substantial doubt is alleviated as a result of consideration of management’s plans, the entity should disclose information that enables users of the financial statements to understand all of the following (or refer to similar information disclosed elsewhere in the footnotes):
		a.	Principal conditions or events that raised substantial doubt about the entity’s ability to continue as a going concern (before consideration of management’s plans).
		b.	Management’s evaluation of the significance of those conditions or events in relation to the entity’s ability to meet its obligations.
		c.	Management’s plans that alleviated substantial doubt about the entity’s ability to continue as a going concern.
	If conditions or events raise substantial doubt about an entity’s ability to continue as a going concern, but the substantial doubt is not alleviated after consideration of management’s plans, an entity should include a statement in the footnotes indicating that there is substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued (or available to be issued). Additionally, the entity should disclose information that enables users of the financial statements to understand all of the following:
		a.	Principal conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern.
		b.	Management’s evaluation of the significance of those conditions or events in relation to the entity’s ability to meet its obligations.
		c.	Management’s plans that are intended to mitigate the conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern.
	The amendments in this Update are effective for the annual period ending after December 15, 2016, and for the annual periods and interim periods thereafter. Early application is permitted. The Company is currently evaluating the impact of the adoptions of ASU 2014-15 on its consolidated financial statements.
Minority Interest (Noncontrolling Interest)	A subsidiary of the Company has minority members, representing ownership interests of 1.38% at December 31, 2013 and December 31, 2014. The Company accounts for these minority, or noncontrolling interests pursuant to ASC 810-10-65 whereby gains and losses in a subsidiary with a noncontrolling interest are allocated to the noncontrolling interest based on the ownership percentage of the noncontrolling interest, even if that allocation results in a deficit noncontrolling interest balance.

NOTE_3_PROPERTY_EQUIPMENT_Tabl

NOTE 3. PROPERTY & EQUIPMENT (Tables)	12 Months Ended
	Dec. 31, 2014
Note 3. Property Equipment Tables
Fixed asset values	Fixed asset values recorded at cost are as follows:
		31-Dec-14			31-Dec-13
	Office and Lab Equipment	$	32,127		$	31,616
	Furniture and fixtures		11,556			11,556
			43,683			43,683
	Less accumulated depreciation		(43,229	)		(42,453	)
	Total	$	454		$	1,230

NOTE_4_NOTES_PAYABLE_Tables

NOTE 4. NOTES PAYABLE (Tables)	12 Months Ended
	Dec. 31, 2014
Note 4. Notes Payable Tables
Notes Payables		31-Dec-14			31-Dec-13
	Note payable to related party, unsecured, due 8/3/2012, interest rate 0%.	$	1,950		$	1,950
	Notes payable to related party, unsecured, due 12/31/2012, interest rate 0%.	$	11,810		$	11,810
	Note payable to related party, unsecured, $731,763, 5-years at 0% simple interest, due 7/1/2016, payment amounts vary each month, various late penalties.	$	726,763		$	726,763
	Note payable to non-related party, unsecured, due 2/8/12, quarterly interest due, convertible at holder’s option at $0.3235688 per TBT - DE share, interest rate 30%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	10,000		$	10,000
	Note payable to non-related party, unsecured, due 2/8/12, quarterly interest due, convertible at holder’s option at $0.3235688 per TBT - DE share, interest rate 30%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	25,000		$	25,000
	Note payable to non-related party, unsecured, due 2/17/12, quarterly interest due, convertible at holder’s option at $0.3235688 per TBT - DE share, interest rate 30%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	25,000		$	25,000
	Note payable to non-related party, unsecured, due 2/18/12, quarterly interest due, convertible at holder’s option at $0.3235688 per TBT - DE share, interest rate 30%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	10,000		$	10,000
	Note payable to non-related party, unsecured, due 2/18/13, annual interest due, convertible at holder’s option at $0.3235688 per TBT-DE share, interest rate 18%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	750		$	750
	Note payable to non-related party, unsecured, due 2/18/13, annual interest due, convertible at holder’s option at $0.3235688 per TBT-DE share, interest rate 18%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	6,875		$	6,875
	Note payable to non-related party, unsecured, due 2/15/13, annual interest due, convertible at holder’s option at $0.3235688 per TBT-DE share, interest rate 12%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	2,500		$	2,500
	Note payable to non-related party, unsecured, due 2/20/13, annual interest due, convertible at holder’s option at $0.3235688 per TBT-DE share, interest rate 12%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	3,750		$	3,750
	Note payable to non-related party, unsecured, due 2/21/13, annual interest due, convertible at holder’s option at $0.3235688 per TBT-DE. share, interest rate 12%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	2,625		$	2,625
	Note payable to non-related party, unsecured, due 3/20/13, annual interest due, convertible at holder’s option at $0.3235688 per TBT-DE share, interest rate 12%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	5,433		$	5,433
	Note payable to non-related party, unsecured, due 3/22/13, annual interest due, convertible at holder’s option at $0.3235688 per TBT-DE share, interest rate 12%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	3,203		$	3,203
	Note payable to non-related party, unsecured, due 2/25/13, annual interest due, convertible at holder’s option at 51% of market as defined, interest rate 8%, conversion limited to total beneficial ownership of 4.99%. (Fully converted at December 31, 2014).	$	-		$	19,250
	Note payable to non-related party, unsecured, due 4/19/13, annual interest due, convertible at holder’s option at 51% of market as defined, interest rate 8%, conversion limited to total beneficial ownership of 4.99%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue and/or the continued conversion of the company’s stock.	$	6,605		$	52,500
	Note payable to non-related party, unsecured, due 08/29/2013, simple interest 8% convertible at holder’s option at $.249 per TBT-CA share.	$	15,000		$	15,000
	Currently in default.
	Note payable to non-related party, unsecured, due 03/01/2013, simple interest 9%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	5,000		$	5,000
	Note payable to non-related party, unsecured, due 12/13/2013, simple interest 7%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	5,342		$	5,342
	Note payable to non-related party, unsecured, due 01/31/2013, simple interest 18%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	3,938		$	3,938
	Note payable to non-related party, unsecured, due on demand, simple interest 7%, convertible at anytime into common stock at 65% of market closing price on previous day	$	-		$	25,000
	Note payable to non-related party, unsecured, due 01/07/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interest	$	15,000		$	15,000
	to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.
	Note payable to non-related party, unsecured, due 01/15/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	5,000		$	5,000
	Note payable to non-related party, unsecured, due 01/20/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	65,272		$	65,272
	Note payable to non-related party, unsecured, due 03/28/2013, $13,000 in interest (1 month). Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	17,000		$	32,000
	Note payable to non-related party, unsecured, due 01/23/2014, simple interest 9%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	50,000		$	50,000
	Note payable to non-related party, unsecured, due 04/28/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	9,440		$	9,440
	Note payable to non-related party, unsecured, due 05/05/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	50,060		$	50,060
	Note payable to non-related party, unsecured, due 07/02/2014, simple interest 9%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	15,000		$	15,000
	Note payable to non-related party, unsecured, due 10/25/2013, simple interest 18%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	2,000		$	2,000
	Note payable to non-related party, unsecured, due 07/29/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interestto be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	1,900		$	1,900
	Note payable to non-related party, unsecured, due 09/19/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	10,000		$	10,000
	Note payable to non-related party, unsecured, due 09/19/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	65,000		$	65,000
	Note payable to non-related party, unsecured, due 09/29/2014, simple interest 7%, default interest 10%, stock option. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	20,000		$	20,000
	Note payable to non-related party, unsecured, due 12/27/2013, simple interest 9%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	15,000		$	15,000
	Note payable to non-related party, unsecured, due 10/28/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	2,500		$	2,500
	Note payable to non-related party, unsecured, due 10/29/2014, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenu. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	10,000		$	10,000
	Note payable to non-related party, unsecured, due 11/10/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	5,000		$	5,000
	Note payable to non-related party, unsecured, due 11/20/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	20,000		$	20,000
	Note payable to non-related party, unsecured, due 12/02/2014, simple interest 7%, default interest 10%, Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	5,000		$	5,000
	Note payable to non-related party, unsecured, due 1/27/2014, simple interest 10%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	4,235		$	5,000
	Note payable to non-related party, unsecured, due 1/07/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	25,000		$	-
	Note payable to non-related party, unsecured, due 1/28/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	1,253		$	-
	Note payable to non-related party, unsecured, due 1/29/2015, simple interest 7%, default interest 10%. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	3,500		$	-
	Note payable to non-related party, unsecured, due 2/10/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	990		$	-
	Note payable to non-related party, unsecured, due 2/17/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	4,500		$	-
	Note payable to non-related party, unsecured, due 2/20/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	5,000		$	-
	Note payable to non-related party, unsecured, due 3/10/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	2,500		$	-
	Note payable to non-related party, unsecured, due 3/31/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	2,500		$	-
	Note payable to non-related party, unsecured, due 4/03/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	5,890		$	-
	Note payable to non-related party, unsecured, due 4/08/2015, interest up to 7%, convertible up to the due date.	$	15,000		$	-
	Note payable to non-related party, unsecured, due 4/10/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	4,331		$	-
	Note payable to non-related party, unsecured, due 4/27/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	2,500		$	-
	Note payable to non-related party, unsecured, due 5/13/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	5,360		$	-
	Note payable to non-related party, unsecured, due 9/11/2014, simple interest 10%. Currently in default. Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue.	$	5,000		$	-
	Note payable to non-related party, unsecured, due 5/26/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	895		$	-
	Note payable to non-related party, unsecured, due 6/10/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	3,207		$	-
	Note payable to non-related party, unsecured, due 6/17/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	600		$	-
	Note payable to non-related party, unsecured, due 7/09/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	3,750		$	-
	Note payable to non-related party, unsecured, due 8/05/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	10,000		$	-
	Note payable to non-related party, unsecured, due 9/03/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	1,000		$	-
Note payable to non-related party, unsecured, due 10/19/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	1,486		$	-
Note payable to non-related party, unsecured, due 10/22/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	3,500		$	-
Note payable to non-related party, unsecured, due 10/28/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	4,360		$	-
Note payable to non-related party, unsecured, due 11/11/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	5,810		$	-
Note payable to non-related party, unsecured, due 11/19/2015, simple interest 7%, default interest 10%, Principal balance including interest to be paid upon the receipt of equity funding and/or sales revenue. Stock option issued as an additional transaction cost for receipt of funds from note payable.	$	15,000		$	-
Note payable to non-related party, unsecured, due 12/02/2015, simple interest 7%, default interest 10%.	$	214,334		$	-
	$	1,617,217		$	1,375,861
Less note discounts		(5,000	)		(22,996	)
Less current - related parties		(697,225	)		(573,516	)
Less current – non-related parties		(871,694	)		(612,342	)
Long-term – related parties	$	43,298		$	167,00
Principal payments	Required principal payments from December 31, 2014 forward are as follows:
	2015		$	1,573,919
	2016		$	43,298
	2017		$	-
	2018		$	-
	2019		$	-
			$	1,617,217

NOTE_6_STOCK_OPTIONS_AND_SUBSC1

NOTE 6. STOCK OPTIONS AND SUBSCRIPTIONS PAYABLE (Tables)	12 Months Ended
	Dec. 31, 2014
Note 6. Stock Options And Subscriptions Payable Tables
Summary of stock option activity for California	A summary of stock option activity for California is as follows:
			Number of				Weighted Average Exercise
			Shares				Price
	Outstanding at December 31, 2013			22,500			$	0.15
	Granted			-				-
	Exercised			20,000				0.35
	Forfeited			-				-
	Outstanding at December 31, 2014			2,500			$	0.1
Schedule of common stock options and warrants California outstanding	Following is a summary of the status of options for California outstanding at December 31, 2014:
	Exercise				Number			Weighted		Weighted				Exercised at
	Price				of Shares			Average		Average				Dec. 31, 2014
								Contractual		Exercise
								Life		Price
	$	0.1				1,500		5 years			0.1				-
	$	0.1				1,000		5 years			0.1				-
	Total				$	2,500				$	0.1			$	-
Summary of stock option activity for Delaware	A summary of stock option activity for Delaware is as follows:
			Number				Weighted
			of Shares				Average
							Exercise
							Price
	Outstanding at December 31, 2013			5,351,413			$	0.09
	Granted			8,403,633				0.02
	Exercised			-				-
	Forfeited			-				-
	Outstanding at December 31, 2014		$	13,755,046			$	0.0295
Schedule of common stock options and warrants Delaware outstanding	Following is a summary of the status of options for Delaware outstanding at December 31, 2014:
	Exercise				Number				Remaining			Weighted				Exercised at
	Price				of Shares				Contractual			Average				Dec. 31, 2014
									Life			Exercise
												Price
	$	0.09				29,678			3 years				0.09				-
	$	0.17				83,333			4 years				0.17				-
	$	0.17				27,778			4 years				0.17				-
	$	0.17				362,624			4 years				0.17				-
	$	0.13				80,914			4 years				0.13				-
	$	0.13				429,086			4 years				0.13				-
	$	0.06				38,000			4 years				0.06				-
	$	0.04				250,000			4 years				0.04				-
	$	0.04				1,625,000			4 years				0.04				-
	$	0.05				400,000			4 years				0.05				-
	$	0.04				75,000			4 years				0.04				-
	$	0.04				300,000			4 years				0.04				-
	$	0.02				300,000			4 years				0.02				-
	$	0.02				1,200,000			4 years				0.02				-
	$	0.04				150,000			4 years				0.04				-
	$	0.0125				1,200,000			5 years				0.0125
	$	0.015				50,137			5 years				0.015				-
	$	0.015				140,000			5 years				0.015				-
	$	0.019				31,256			5 years				0.019				-
	$	0.0161				167,702			5 years				0.0161				-
	$	0.0147				204,082			5 years				0.0147				-
	$	0.02				75,000			5 years				0.02				-
	$	0.0198				75,758			5 years				0.0198				-
	$	0.0213				165,915			5 years				0.0213				-
	$	0.0195				133,262			5 years				0.0195				-
	$	0.0188				79,787			5 years				0.0188				-
	$	0.014				229,714			5 years				0.014				-
	$	0.019				50,000			5 years				0.019				-
	$	0.0127				42,283			5 years				0.0127				-
	$	0.009				213,833			5 years				0.009				-
	$	0.0074				48,649			5 years				0.0074				-
	$	0.006				375,000			5 years				0.006				-
	$	0.0098				612,245			5 years				0.0098				-
	$	0.0098				61,224			5 years				0.0098				-
	$	0.25				25,000			5 years				0.25				-
	$	0.068				450,000			5 years				0.068				-
	$	0.0072				123,828			5 years				0.0072				-
	$	0.0056				375,000			5 years				0.0056				-
	$	0.007				250,000			5 years				0.007				-
	$	0.007				373,714			5 years				0.007				-
	$	0.0041				850,244			5 years				0.0041				-
	$	0.0045				2,000,000			5 years				0.0045				-
	Total					13,755,046						$	0.0295				-

NOTE_1_ORGANIZATION_OPERATIONS2

NOTE 1. ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)	Dec. 31, 2014	Dec. 31, 2013
Note 1. Organization Operations And Summary Of Significant Accounting Policies Details Narrative
Ownership interests	1.38%	1.38%

NOTE_2_RELATED_PARTY_TRANSACTI1

NOTE 2. RELATED PARTY TRANSACTIONS (Details Narrative) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Note 2. Related Party Transactions Details Narrative
Payables due to officers, shareholders and former management	$296,265	$190,765

NOTE_3_PROPERTY_EQUIPMENT_Deta

NOTE 3. PROPERTY & EQUIPMENT (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Note 3. Property Equipment Details
Office and Lab Equipment	$32,127	$31,616
Furniture and fixtures	11,556	11,556
Gross Fixed Assets	43,683	43,683
Less accumulated depreciation	-43,229	-42,453
Total	$454	$1,230

NOTE_3_PROPERTY_EQUIPMENT_Deta1

NOTE 3. PROPERTY & EQUIPMENT (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Note 3. Property Equipment Details Narrative
Depreciation expense	$776	$777

NOTE_4_NOTES_PAYABLE_Details

NOTE 4. NOTES PAYABLE (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Notes Payable	$1,617,217	$1,375,861
Less note discounts	-5,000	-22,996
Less current - related parties	-697,225	-573,516
Less current portion	-871,694	-612,342
Long-term portion	43,298	167,007
Note payable 1 [Member]
Notes Payable	1,950	1,950
Note payable 2 [Member]
Notes Payable	11,810	11,810
Note payable 3 [Member]
Notes Payable	726,763	726,763
Note payable 4 [Member]
Notes Payable	10,000	10,000
Note payable 5 [Member]
Notes Payable	25,000	25,000
Note payable 6 [Member]
Notes Payable	25,000	25,000
Note payable 7 [Member]
Notes Payable	10,000	10,000
Note payable 8 [Member]
Notes Payable	750	750
Note payable 9 [Member]
Notes Payable	6,875	6,875
Note payable 10 [Member]
Notes Payable	2,500	2,500
Note payable 11 [Member]
Notes Payable	3,750	3,750
Note payable 12 [Member]
Notes Payable	2,625	2,625
Note payable 13 [Member]
Notes Payable	5,433	5,433
Note payable 14 [Member]
Notes Payable	3,203	3,203
Note payable 15 [Member]
Notes Payable		19,250
Note payable 16 [Member]
Notes Payable	6,605	52,500
Note payable 17 [Member]
Notes Payable	15,000	15,000
Note payable 18 [Member]
Notes Payable	5,000	5,000
Note payable 19 [Member]
Notes Payable	5,342	5,342
Note payable 20 [Member]
Notes Payable	3,938	3,938
Note payable 21 [Member]
Notes Payable		25,000
Note payable 22 [Member]
Notes Payable	15,000	15,000
Note payable 23 [Member]
Notes Payable	5,000	5,000
Note payable 24 [Member]
Notes Payable	65,272
Note payable 24 [Member]
Notes Payable		65,272
Note payable 25 [Member]
Notes Payable	17,000	32,000
Note payable 26 [Member]
Notes Payable	50,000	50,000
Note payable 27 [Member]
Notes Payable	9,440	9,440
Note payable 28 [Member]
Notes Payable	50,060	50,060
Note payable 29 [Member]
Notes Payable	15,000	15,000
Note payable 30 [Member]
Notes Payable	2,000	2,000
Note payable 31 [Member]
Notes Payable	1,900	1,900
Note payable 32 [Member]
Notes Payable	10,000	10,000
Note payable 33 [Member]
Notes Payable	65,000	65,000
Note payable 34 [Member]
Notes Payable	20,000	20,000
Note payable 35 [Member]
Notes Payable	15,000	15,000
Note payable 36 [Member]
Notes Payable	2,500	2,500
Note payable 37 [Member]
Notes Payable	10,000	10,000
Note payable 38 [Member]
Notes Payable	5,000	5,000
Note payable 39 [Member]
Notes Payable	20,000	20,000
Note payable 40 [Member]
Notes Payable	5,000	5,000
Note payable 41 [Member]
Notes Payable	4,235	5,000
Note payable 42 [Member]
Notes Payable	25,000
Note payable 43 [Member]
Notes Payable	1,253
Note payable 44 [Member]
Notes Payable	3,500
Note payable 45 [Member]
Notes Payable	990
Note payable 46 [Member]
Notes Payable	4,500
Note payable 47 [Member]
Notes Payable	5,000
Note payable 48 [Member]
Notes Payable	2,500
Note payable 49 [Member]
Notes Payable	2,500
Note payable 50 [Member]
Notes Payable	5,890
Note payable 51 [Member]
Notes Payable	15,000
Note payable 52 [Member]
Notes Payable	4,331
Note payable 53 [Member]
Notes Payable	2,500
Note payable 54 [Member]
Notes Payable	5,360
Note payable 55 [Member]
Notes Payable	5,000
Note payable 56 [Member]
Notes Payable	895
Note payable 57 [Member]
Notes Payable	3,207
Note payable 58 [Member]
Notes Payable	600
Note payable 59 [Member]
Notes Payable	3,750
Note payable 60 [Member]
Notes Payable	10,000
Note payable 61 [Member]
Notes Payable	1,000
Note payable 62 [Member]
Notes Payable	1,486
Note payable 63 [Member]
Notes Payable	3,500
Note payable 64 [Member]
Notes Payable	4,360
Note payable 65 [Member]
Notes Payable	5,810
Note payable 66 [Member]
Notes Payable	15,000
Note payable 67 [Member]
Notes Payable	$214,334

NOTE_4_NOTES_PAYABLE_Details_1

NOTE 4. NOTES PAYABLE (Details 1) (USD $)	Dec. 31, 2014
Note 4. Notes Payable Details 1
2015	$1,573,919
2016	43,298
2017
2018
2019
Total principal payment	$1,617,217

NOTE_4_NOTES_PAYABLE_Details_N

NOTE 4. NOTES PAYABLE (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Interest expense	$188,046	$170,428
Beneficial Conversion Feature Interest Expense	32,996	94,161
Note discount	5,000	22,996
Borrowing under convertible notes		110,000
Convertible Notes	103,395	47,500
Fair value adjustments - equity obligation	21,559	11,969
Risk free interest rate	0.21%	0.10%
Dividend yield	0.00%	0.00%
Expected life	1 month
Notes payable - equity obligation payable	$25,456	$150,067
Minimum [Member]
Volatility	128.00%
Maximum [Member]
Volatility	354.00%

NOTE_5_INCOME_TAXES_Details_Na

NOTE 5. INCOME TAXES (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Note 5. Income Taxes Details Narrative
Net operating loss carry forwards	$6,383,000	$5,765,000
Carryforward expiration year	2034	2034
Deferred tax asset	1,277,000	1,153,000
Rate of net operating losses offset by valuation allowance	100.00%	100.00%
Change in the valuation allowance	$123,000	$140,000

NOTE_6_STOCK_OPTIONS_AND_SUBSC2

NOTE 6. STOCK OPTIONS AND SUBSCRIPTIONS PAYABLE (Details) (USD $)	12 Months Ended
	Dec. 31, 2014
Number of Shares
Outstanding at end of period	2,500
Weighted Average Exercise Price
Outstanding at end of period	$0.03
California
Number of Shares
Outstanding at beginning of period	22,500
Granted
Exercised	20,000
Forfeited
Outstanding at end of period	2,500
Weighted Average Exercise Price
Outstanding at beginning of period	$0.15
Granted
Exercised	$0.35
Forfeited
Outstanding at end of period	$0.10
Delaware
Number of Shares
Outstanding at beginning of period	5,351,413
Granted	8,403,633
Exercised
Forfeited
Outstanding at end of period	13,755,046
Weighted Average Exercise Price
Outstanding at beginning of period	$0.09
Granted	$0.02
Exercised
Forfeited
Outstanding at end of period	$0.03

NOTE_6_STOCK_OPTIONS_AND_SUBSC3

NOTE 6. STOCK OPTIONS AND SUBSCRIPTIONS PAYABLE (Details 1) (USD $)	12 Months Ended
	Dec. 31, 2014
Number of shares	2,500
Weighted average exercise price	$0.10
Exercised at Dec. 31, 2014
0.10 California
Number of shares	1,500
Weighted average contractual life	5 years
Weighted average exercise price	$0.10
Exercised at Dec. 31, 2014
0.10 California
Number of shares	1,000
Weighted average contractual life	5 years
Weighted average exercise price	$0.10
Exercised at Dec. 31, 2014

NOTE_6_STOCK_OPTIONS_AND_SUBSC4

NOTE 6. STOCK OPTIONS AND SUBSCRIPTIONS PAYABLE (Details 2) (USD $)	12 Months Ended
	Dec. 31, 2014
Number of Shares	13,755,046
Weighted Average Exercise Price	$0.03
Exercised at December 31, 2014
0.0900 Delaware
Exercise Price	$0.09
Number of Shares	29,678
Weighted Average Remaining Contractual Life (Years)	3 years
Weighted Average Exercise Price	$0.09
Exercised at December 31, 2014
0.1700 Delaware
Exercise Price	$0.17
Number of Shares	83,333
Weighted Average Remaining Contractual Life (Years)	4 years
Weighted Average Exercise Price	$0.17
Exercised at December 31, 2014
0.1700 Delaware
Exercise Price	$0.17
Number of Shares	27,778
Weighted Average Remaining Contractual Life (Years)	4 years
Weighted Average Exercise Price	$0.17
Exercised at December 31, 2014
0.1700 Delaware
Exercise Price	$0.17
Number of Shares	362,624
Weighted Average Remaining Contractual Life (Years)	4 years
Weighted Average Exercise Price	$0.17
Exercised at December 31, 2014
0.1300 Delaware
Exercise Price	$0.13
Number of Shares	80,914
Weighted Average Remaining Contractual Life (Years)	4 years
Weighted Average Exercise Price	$0.13
Exercised at December 31, 2014
0.1300 Delaware
Exercise Price	$0.13
Number of Shares	429,086
Weighted Average Remaining Contractual Life (Years)	4 years
Weighted Average Exercise Price	$0.13
Exercised at December 31, 2014
0.0600 Delaware
Exercise Price	$0.06
Number of Shares	38,000
Weighted Average Remaining Contractual Life (Years)	4 years
Weighted Average Exercise Price	$0.06
Exercised at December 31, 2014
0.0400 Delaware
Exercise Price	$0.04
Number of Shares	250,000
Weighted Average Remaining Contractual Life (Years)	4 years
Weighted Average Exercise Price	$0.04
Exercised at December 31, 2014
0.0400 Delaware
Exercise Price	$0.04
Number of Shares	1,625,000
Weighted Average Remaining Contractual Life (Years)	4 years
Weighted Average Exercise Price	$0.04
Exercised at December 31, 2014
0.0500 Delaware
Exercise Price	$0.05
Number of Shares	400,000
Weighted Average Remaining Contractual Life (Years)	4 years
Weighted Average Exercise Price	$0.05
Exercised at December 31, 2014
0.0400 Delaware
Exercise Price	$0.04
Number of Shares	75,000
Weighted Average Remaining Contractual Life (Years)	4 years
Weighted Average Exercise Price	$0.04
Exercised at December 31, 2014
0.0400 Delaware
Exercise Price	$0.04
Number of Shares	300,000
Weighted Average Remaining Contractual Life (Years)	4 years
Weighted Average Exercise Price	$0.04
Exercised at December 31, 2014
0.0200 Delaware
Exercise Price	$0.02
Number of Shares	300,000
Weighted Average Remaining Contractual Life (Years)	4 years
Weighted Average Exercise Price	$0.02
Exercised at December 31, 2014
0.0200 Delaware
Exercise Price	$0.02
Number of Shares	1,200,000
Weighted Average Remaining Contractual Life (Years)	4 years
Weighted Average Exercise Price	$0.02
Exercised at December 31, 2014
0.0400 Delaware
Exercise Price	$0.04
Number of Shares	150,000
Weighted Average Remaining Contractual Life (Years)	4 years
Weighted Average Exercise Price	$0.04
Exercised at December 31, 2014
0.0125 Delaware
Exercise Price	$0.01
Number of Shares	1,200,000
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.01
0.0150 Delaware
Exercise Price	$0.02
Number of Shares	50,137
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.02
Exercised at December 31, 2014
0.0150 Delaware
Exercise Price	$0.02
Number of Shares	140,000
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.02
Exercised at December 31, 2014
0.0190 Delaware
Exercise Price	$0.02
Number of Shares	31,256
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.02
Exercised at December 31, 2014
0.0161 Delaware
Exercise Price	$0.02
Number of Shares	167,702
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.02
Exercised at December 31, 2014
0.0147 Delaware
Exercise Price	$0.01
Number of Shares	204,082
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.01
Exercised at December 31, 2014
0.0200 Delaware
Exercise Price	$0.02
Number of Shares	75,000
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.02
Exercised at December 31, 2014
0.0198 Delaware
Exercise Price	$0.02
Number of Shares	75,758
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.02
Exercised at December 31, 2014
0.0213 Delaware
Exercise Price	$0.02
Number of Shares	165,915
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.02
Exercised at December 31, 2014
0.0195 Delaware
Exercise Price	$0.02
Number of Shares	133,262
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.02
Exercised at December 31, 2014
0.0188 Delaware
Exercise Price	$0.02
Number of Shares	79,787
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.02
Exercised at December 31, 2014
0.0140 Delaware
Exercise Price	$0.01
Number of Shares	229,714
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.01
Exercised at December 31, 2014
0.0190 Delaware
Exercise Price	$0.02
Number of Shares	50,000
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.02
Exercised at December 31, 2014
0.0127 Delaware
Exercise Price	$0.01
Number of Shares	42,283
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.01
Exercised at December 31, 2014
0.0090 Delaware
Exercise Price	$0.01
Number of Shares	213,833
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.01
Exercised at December 31, 2014
0.0074 Delaware
Exercise Price	$0.01
Number of Shares	48,649
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.01
Exercised at December 31, 2014
0.0060 Delaware
Exercise Price	$0.01
Number of Shares	375,000
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.01
Exercised at December 31, 2014
0.0098 Delaware
Exercise Price	$0.01
Number of Shares	612,245
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.01
Exercised at December 31, 2014
0.0098 Delaware
Exercise Price	$0.01
Number of Shares	61,224
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.01
Exercised at December 31, 2014
0.2500 Delaware
Exercise Price	$0.25
Number of Shares	25,000
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.25
Exercised at December 31, 2014
0.0680 Delaware
Exercise Price	$0.07
Number of Shares	450,000
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.07
Exercised at December 31, 2014
0.0072 Delaware
Exercise Price	$0.01
Number of Shares	123,828
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.01
Exercised at December 31, 2014
0.0056 Delaware
Exercise Price	$0.01
Number of Shares	375,000
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.01
Exercised at December 31, 2014
0.0070 Delaware
Exercise Price	$0.01
Number of Shares	250,000
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.01
Exercised at December 31, 2014
0.0070 Delaware
Exercise Price	$0.01
Number of Shares	373,714
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.01
Exercised at December 31, 2014
0.0041 Delaware
Exercise Price	$0
Number of Shares	850,244
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.00
Exercised at December 31, 2014
0.0045 Delaware
Exercise Price	$0
Number of Shares	2,000,000
Weighted Average Remaining Contractual Life (Years)	5 years
Weighted Average Exercise Price	$0.00
Exercised at December 31, 2014

NOTE_6_STOCK_OPTIONS_AND_SUBSC5

NOTE 6. STOCK OPTIONS AND SUBSCRIPTIONS PAYABLE (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Stock subscription payable - current	$28,067	$26,000
Common stock issued for stock subscription payment	26,000
Non employee stock options [Member]
Stock options outstanding		22,500	22,500
Outstanding balance	2,500
Option terms expiration	Jan-15	Jan-15
Option expired	8,403,633	5,351,413
Option granted	29,678	5,321,735
Dividend yield	0.00%	0.00%
Expected lives	5 years	5 years
Compensation expense	$69,886	$145,997
Non employee stock options [Member] | Minimum [Member]
Options exercisable exercise price	$0.10
Risk free interest rate	1.55%	7.00%
Volatility rate	147.00%	179.00%
Non employee stock options [Member] | Maximum [Member]
Options exercisable exercise price	$0.15
Risk free interest rate	1.77%	14.00%
Volatility rate	178.00%	186.00%

NOTE_7_GOING_CONCERN_Details_N

NOTE 7. GOING CONCERN (Details Narrative) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Note 7. Going Concern Details Narrative
Accumulated deficit	($15,777,222)	($15,032,660)